Kayoko Mihara

815 total citations
19 papers, 672 citations indexed

About

Kayoko Mihara is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Oncology. According to data from OpenAlex, Kayoko Mihara has authored 19 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Hematology and 6 papers in Oncology. Recurrent topics in Kayoko Mihara's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), PARP inhibition in cancer therapy (6 papers) and Platelet Disorders and Treatments (4 papers). Kayoko Mihara is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), PARP inhibition in cancer therapy (6 papers) and Platelet Disorders and Treatments (4 papers). Kayoko Mihara collaborates with scholars based in Japan. Kayoko Mihara's co-authors include Nobuya Matsuoka, Akinori Iwashita, Kouji Hattori, Junya Ishida, Hirofumi Yamamoto, Seitaro Mutoh, Akira Moriguchi, Yasuhiro Kita, Yoshiyuki Kido and Shunji Yamazaki and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Kayoko Mihara

19 papers receiving 652 citations

Peers

Countries citing papers authored by Kayoko Mihara

Since Specialization

Citations

This map shows the geographic impact of Kayoko Mihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kayoko Mihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kayoko Mihara more than expected).

Fields of papers citing papers by Kayoko Mihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kayoko Mihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kayoko Mihara. The network helps show where Kayoko Mihara may publish in the future.

Co-authorship network of co-authors of Kayoko Mihara

This figure shows the co-authorship network connecting the top 25 collaborators of Kayoko Mihara. A scholar is included among the top collaborators of Kayoko Mihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kayoko Mihara. Kayoko Mihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Brain Adenosine A_2AReceptor Occupancy by a Novel A₁/A_2AReceptor Antagonist, ASP5854, in Rhesus Monkeys: Relationship to Anticataleptic Effect 2008 ·Journal of Nuclear Medicine ·Takuma Mihara, Akihiro Noda, Hiroshi Arai, Kayoko Mihara, Akinori Iwashita, Yoshihiro Murakami, (unknown), Sosuke Miyoshi, Shintaro Nishimura, Nobuya Matsuoka	16
2	Pharmacological Characterization of a Novel, Potent Adenosine A1 and A2A Receptor Dual Antagonist, 5-[5-Amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1 H)-one (ASP5854), in Models of Parkinson’s Disease and Cognition 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Takuma Mihara, Kayoko Mihara, Junko Yarimizu, Yasuyuki Mitani, (unknown), Hiroko Yamamoto, (unknown), Atsushi Akahane, Akinori Iwashita, Nobuya Matsuoka	67
3	Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase 2007 ·Bioorganic & Medicinal Chemistry Letters ·Kouji Hattori, Yoshiyuki Kido, Hirofumi Yamamoto, Junya Ishida, Akinori Iwashita, Kayoko Mihara	28
4	Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor δ-Selective Agonists in Vitro and in Vivo 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Akinori Iwashita, Yuko Muramatsu, Takao Yamazaki, (unknown), Yasuhiro Kita, Shunji Yamazaki, Kayoko Mihara, Akira Moriguchi, Nobuya Matsuoka	127
5	Design, synthesis, and structure–activity relationships of potent GPIIb/IIIa antagonists: discovery of FK419 2005 ·Bioorganic & Medicinal Chemistry ·Toshio Yamanaka, Mitsuru Ohkubo, (unknown), (unknown), (unknown), Toshiaki Aoki, Kayoko Mihara, Jiro Seki, Masayuki Kato	9
6	FK419, a Novel Nonpeptide GPIIb/IIIa Antagonist, Restores Microvascular Patency and Improves Outcome in the Guinea-Pig Middle Cerebral Artery Thrombotic Occlusion Model: Comparison with Tirofiban 2005 ·Journal of Cerebral Blood Flow & Metabolism ·Akira Moriguchi, Masashi Maeda, Kayoko Mihara, Toshiaki Aoki, Nobuya Matsuoka, Seitaro Mutoh	10
7	Association of the antagonism of von Willebrand factor but not fibrinogen by platelet αIIbβ3 antagonists with prolongation of bleeding time 2005 ·Journal of Thrombosis and Haemostasis ·Toshiaki Aoki, Yoshiaki Tomiyama, S. Honda, Kayoko Mihara, Toshio Yamanaka, (unknown), Akira Moriguchi, Seitaro Mutoh	5
8	4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Junya Ishida, Kouji Hattori, Hirofumi Yamamoto, Akinori Iwashita, Kayoko Mihara, Nobuya Matsuoka	33
9	Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling 2005 ·Bioorganic & Medicinal Chemistry ·Junya Ishida, Hirofumi Yamamoto, Yoshiyuki Kido, Kazunori Kamijo, Kenji Murano, Hiroshi Miyake, Mitsuru Ohkubo, Takayoshi Kinoshita, Masaichi Warizaya, Akinori Iwashita, Kayoko Mihara, Nobuya Matsuoka, Kouji Hattori	66
10	Prohemorrhagic and Bleeding Time Activities of Recombinant Tissue Plasminogen Activator, Heparin, Aspirin, and a Glycoprotein IIb/IIIa Antagonist 2005 ·Journal of Neurotrauma ·Kayoko Mihara, Toshiaki Aoki, Akira Moriguchi, Masashi Maeda, Yasuhisa Furuichi, Nobuya Matsuoka, Seitaro Mutoh	9
11	FK419, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, Ameliorates Brain Infarction Associated with Thrombotic Focal Cerebral Ischemia in Monkeys: Comparison with Tissue Plasminogen Activator 2005 ·Journal of Cerebral Blood Flow & Metabolism ·Masashi Maeda, Akira Moriguchi, Kayoko Mihara, Toshiaki Aoki, Hiroyuki Takamatsu, Nobuya Matsuoka, Seitaro Mutoh, Toshio Goto	15
12	Characterization of the anti‐platelet actions of FK419, a novel non‐peptide antagonist of platelet GPIIb/IIIa 2004 ·Drug Development Research ·Kayoko Mihara, Toshiaki Aoki, Akira Moriguchi, Hiroko Yamamoto, Masashi Maeda, (unknown), Toshio Yamanaka, Mitsuru Ohkubo, Nobuya Matsuoka, Jiro Seki, Seitaro Mutoh	23
13	A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Akinori Iwashita, Kayoko Mihara, (unknown), (unknown), Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka, Seitaro Mutoh	32
14	Neuroprotective Effects of a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, 2-{3-[4-(4-Chlorophenyl)-1-piperazinyl] propyl}-4(3 H)-quinazolinone (FR255595), in an in Vitro Model of Cell Death and in Mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson’s Disease 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Akinori Iwashita, (unknown), Kayoko Mihara, Kouji Hattori, Hirofumi Yamamoto, Junya Ishida, Nobuya Matsuoka, Seitaro Mutoh	55
15	Restoration of middle cerebral artery thrombosis by novel glycoprotein IIb/IIIa antagonist FK419 in guinea pig 2004 ·European Journal of Pharmacology ·Akira Moriguchi, Kayoko Mihara, Toshiaki Aoki, Masashi Maeda, (unknown), Nobuya Matsuoka, Seitaro Mutoh	6
16	Antithrombotic Effects of FK419, a Novel Nonpeptide Platelet GPIIb/IIIa Antagonist, in a Guinea Pig Photochemically Induced Middle Cerebral Artery Thrombosis Model: Comparison with Ozagrel and Argatroban 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Akira Moriguchi, Toshiaki Aoki, Kayoko Mihara, (unknown), Nobuya Matsuoka, Seitaro Mutoh	8
17	An application of a new planar positron imaging system (PPIS) in a small animal: MPTP-induced Parkinsonism in mouse 2004 ·Annals of Nuclear Medicine ·Hiroyuki Takamatsu, Takeharu Kakiuchi, Akihiro Noda, Hiroshi Uchida, (unknown), (unknown), Akinori Iwashita, Kayoko Mihara, Shunji Yamazaki, Nobuya Matsuoka, Hideo Tsukada, Shintaro Nishimura	8
18	Rational Approaches to Discovery of Orally Active and Brain-Penetrable Quinazolinone Inhibitors of Poly(ADP-ribose)polymerase 2004 ·Journal of Medicinal Chemistry ·Kouji Hattori, Yoshiyuki Kido, Hirofumi Yamamoto, Junya Ishida, Kazunori Kamijo, Kenji Murano, Mitsuru Ohkubo, Takayoshi Kinoshita, Akinori Iwashita, Kayoko Mihara, (unknown), Nobuya Matsuoka, Yoshinori TERAMURA, Hiroshi Miyake	80
19	Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig 2003 ·European Journal of Pharmacology ·Yasuko Kato, Yasuhiro Kita, (unknown), Mie Nishio, Kayoko Mihara, Kiyotaka Ito, Toshio Yamanaka, Jiro Seki, Susumu Miyata, Seitaro Mutoh	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact